| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.007 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |